MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1

MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression

(2015) Lekun Fang et al.   Oncotarget

Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy

(2014) Y. Chen et al.   APOPTOSIS

MicroRNAs in Colorectal Cancer: from Diagnosis to Targeted Therapy

(2014) Ayla Valinezhad Orang et al.   Asian Pacific Journal of Cancer Prevention

Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

(2014) Qiong Wu et al.   CANCER LETTERS

Targeting the microRNA-regulating DNA damage/repair pathways in cancer

(2014) Giulia Bottai et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

PHLPP Is a Negative Regulator of RAF1, Which Reduces Colorectal Cancer Cell Motility and Prevents Tumor Progression in Mice

(2014) Xin Li et al.   GASTROENTEROLOGY

miR200c Attenuates P-gp-Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

(2014) H. Sui et al.   MOLECULAR CANCER THERAPEUTICS

Acquired resistance to EGFR-targeted therapies in colorectal cancer

(2014) Beth O. Van Emburgh et al.   Molecular Oncology

MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance

(2014) Chang Gong Lee et al.   PLoS One

MicroRNA-21 as a potential colon and rectal cancer biomarker

(2014) Tao Li   WORLD JOURNAL OF GASTROENTEROLOGY

MicroRNAs 146a and 147b Biomarkers for Colorectal Tumor’s Localization

(2014) Inés Omrane et al.   Biomed Research International

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

(2013) Y Shen et al.   BRITISH JOURNAL OF CANCER

MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer

(2013) Neha Nagpal et al.   CARCINOGENESIS

microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2

(2013) W.-T. Liao et al.   CLINICAL CANCER RESEARCH

microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1

(2013) M. M. Streppel et al.   CLINICAL CANCER RESEARCH

Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status

(2013) Gianpiero Di Leva et al.   PLoS Genetics

Clinical significance of microRNA-93 downregulation in human colon cancer

(2012) Zhi-Gang Xiao et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells

(2012) Weiwei Cheng et al.   FEBS Journal

Identification and functional screening of microRNAs highly deregulated in colorectal cancer

(2012) Petra Faltejskova et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1

(2011) Shuai Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells

(2011) Ke Xu et al.   MOLECULAR CARCINOGENESIS

Colorectal cancer

(2010) David Cunningham et al.   LANCET

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Apoptomirs: small molecules have gained the license to kill

(2009) Andrea Vecchione et al.   ENDOCRINE-RELATED CANCER

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

(2008) R. Bianco et al.   CLINICAL CANCER RESEARCH

Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis

(2008) J Liu et al.   ONCOGENE